Clinical Trial Update: Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Ziv-Aflibercept with fluorouracil and leucovorin for Stage IV colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Mucinous Adenocarcinoma of the Colon
• Mucinous Adenocarcinoma of the Rectum
• Rectal Cancer
• Signet Ring Adenocarcinoma of the Colon
• Signet Ring Adenocarcinoma of the Rectum

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin calcium (calcium folinate)
• Zaltrap (ramucirumab)

Snippet

Sponsor: University of Southern California | Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 2 | Status: WITHDRAWN